ADVERTISEMENT
infectious disease header

Infection

Meningitis Possible therapeutic alternatives
Empiric therapy (Age < 50 years) Common pathogens
(Cefotaxime 2 grams IVPB q4h or Ceftriaxone 2 grams IVPB q12h) + dexamethasone (0.4mg/kg q12h x 2 days given 30 minutes prior to antibiotics) + Vancomycin 1 gram IVPB q12h (may need higher doses).   May also add Rifampin 600mg po qd or 300mg po bid.
If severe penicillin allergy:
Chloramphenicol 1g IV q6h + Vancomycin +/- Rifampin.
Age > 50 years or alcoholism or other debilitating disease. Common pathogens
Ampicillin 2 grams IVPB q4h + [Ceftriaxone 2 grams IVPB q12h or Cefotaxime 2 grams IVPB q4-6h]  + dexamethasone.  
Ampicillin 2g IV q4h + vancomycin 1g IV q12h plus either  [Cefotaxime 2g IV q4-6h or Ceftriaxone 2g IV q12-24h ]
If severe penicillin allergy:
 Vancomycin 1 gram IVPB q12h + Bactrim 15-20 mg/kg/day in 4 divided doses pending culture results. or  
[Chloramphenicol 1g IV q6h + vancomycin +/- rifampin 300mg PO or IV bid]
Trauma or post neurosurgery Common pathogens
Vancomycin 1 gram IVPB q6-12h + Ceftazidime 2 grams IVPB q8h.  // If gram negative bacilli are suspected add Gentamycin IVPB +/- intrathecally.
Impaired cellular immunity Common pathogens
Ampicillin 2 grams IVPB q4h + Ceftazidime 2 grams IVPB q8h.  //  //
If severe penicillin allergy:
Bactrim 15-20mg/kg/day in 4 divided doses. May add Gentamicin
If Listeria present: cephalosporins are not effective.
N.meningitidis confirmed  
Penicillin G  4 million units IVPB q4h. 
If severe penicillin allergy:
Chloramphenicol 4 to 6 grams/day in 4 divided doses.

Images

Meningies

References - Infectious Disease Section

Infectious Disease References

Disclaimer

The authors make no claims of the accuracy of the information contained herein; and these suggested doses are not a substitute for clinical judgement. Neither GlobalRPh Inc. nor any other party involved in the preparation of this program shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material.
PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.   
Read the disclaimer